Advancing Genetic and Biomarker Market Through Innovation, Partnerships, and Patient Engagement in Q3 2025

Companies advanced personalized and early detection approaches through new test launches, expanded collaborations, and integrated support programs.

BostonGene partnered with SWOG to advance biomarker-driven, personalized cancer care strategies.

Exact Sciences launched new cancer diagnostics, including Cancerguard, Medicare-covered Oncodetect, and a licensed blood-based colorectal screening test from Freenome.

Galleri promoted its multi-cancer early detection test through personal stories and seasonal campaigns emphasizing early detection.

LabCorp launched the first FDA-cleared Alzheimer’s blood test, highlighted the role of biomarkers in diagnostics, and supported outreach campaigns such as “Sharing Their Truth” and Hero Gum.

Personalis expanded its partnership with Tempus to include colorectal cancer and initiated the CATE trial focused on breast cancer.

Ambry Genetics promoted its CARE program for high-risk support, Patient for Life for ongoing care, and educational initiatives, including Classifi, The Gene Scene, and Ambry Knows Genes.